PULSE BIOSCIENCES, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $350,000 | $0 | $0 | $700,000 | $1.4M |
| Operating income | -$76.9M | -$56.3M | -$43.6M | -$58.1M | -$63.0M |
| Cost of revenue | $539,000 | $0 | $0 | $11.9M | $600,000 |
| Cash from operations | -$54.1M | -$36.3M | -$33.0M | -$47.0M | -$54.1M |
| Capital expenditure | $315,000 | $125,000 | $121,000 | $401,000 | $437,000 |
| Free cash flow | -$54.4M | -$36.5M | -$33.2M | -$47.4M | -$54.5M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $94.5M | $132.5M | $59.2M | $77.9M | $54.2M |
| Total liabilities | $13.9M | $17.6M | $14.8M | $80.1M | $18.6M |
Shares outstanding 69.2M · Free float 95.8%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.